Skip to main content
OpenTrials

Clinical trial condition

Renal Cell Carcinoma

Explore clinical trials studying Renal Cell Carcinoma. Study availability and eligibility vary by location and protocol.

416 public trials 76 recruiting studies
Refine in advanced search Browse all conditions

Renal Cell Carcinoma trial results

Recruiting

Testing of Bevacizumab, Erlotinib, and Atezolizumab in Combination for Advanced-Stage Kidney Cancer

NCT04981509

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +21 more
Locations
  • UC San Diego Moores Cancer Center La Jolla, California, United States
  • Emory University Hospital Midtown Atlanta, Georgia, United States
  • Emory University Hospital/Winship Cancer Institute Atlanta, Georgia, United States
  • Emory Saint Joseph's Hospital Atlanta, Georgia, United States
View all 13 locations
View Trial Details
Recruiting

Safety, PK and Efficacy of QXL138AM in Patients With Solid Tumors and Multiple Myeloma

NCT06582017

Conditions
Adenocarcinoma, Adnexal Diseases, Breast Cancer, +54 more
Locations
  • University of Southern California Los Angeles, California, United States
  • Cedars-Sanai Medical Center - Samuel Oschin Comprehensive Cancer Los Angeles, California, United States
  • Cedars-Sanai Medical Center Los Angeles, California, United States
  • Hoag Memorial Hospital Presbyterian Newport, California, United States
View Trial Details
Recruiting

A Study to Investigate Safety of AZD6750 in Adult Participants With Select Advanced or Metastatic Solid Tumors

NCT07115043

Conditions
Adenocarcinoma, Breast Diseases, Breast Neoplasms, +58 more
Locations
  • Research Site Grand Rapids, Michigan, United States
  • Research Site St Louis, Missouri, United States
  • Research Site Pittsburgh, Pennsylvania, United States
  • Research Site Houston, Texas, United States
View all 13 locations
View Trial Details
Recruiting

Study of DCC-2812 in Participants With Advanced Genitourinary Cancers

NCT06966024

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +17 more
Locations
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
  • University of Michigan Ann Arbor, Michigan, United States
  • Fox Chase Cancer Center Philadelphia, Pennsylvania, United States
  • Vanderbilt- Ingram Cancer Center Nashville, Tennessee, United States
View Trial Details
Recruiting

A First-in-Human Study of BMS-986506 in Participants With Advanced Clear Cell Renal Cell Carcinoma (ccRCC)

NCT07195682

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +15 more
Locations
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
  • Memorial Sloan Kettering Cancer Center New York, United States
  • Fox Chase Cancer Center Philadelphia, Pennsylvania, United States
  • SCRI Oncology Partners Nashville, Tennessee, United States
View Trial Details

Related conditions